Permanent Pacing Treatment: Conventional DDDR, Antitachycardia Pacing or Atrial Defibrillator?

  • M. Santini
  • R. Ricci
  • C. Pignalberi
  • M. Russo
  • B. Magris
  • L. Santini
Conference paper


Atrial fibrillation is the most common arrhythmia in clinical practice and its incidence is increasing due to the aging of the population. It is associated with major clinical complications, such as heart failure, acute myocardial infarction, and stroke, and with impaired quality of life [1,2]. Antiarrhythmic drugs have been widely used for cardioversion and maintenance of sinus rhythm, but they showed limited and usually temporary efficacy [3]. In consequence, several nonpharmacological therapies including physiological pacing, pacing prevention algorithms, antitachy pacing therapies, and low-energy internal cardioversion have been introduced to treat drug-refractory arrhythmias [4–6], and have been implemented in multifunction implantable devices.


Atrial Fibrillation Atrial Flutter Paroxysmal Atrial Fibrillation Atrial Arrhythmia Atrial Pace 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 22:983–988PubMedCrossRefGoogle Scholar
  2. 2.
    Hamer ME, Blumenthal JA, McCarthy EA, Phillips BG, Pritchett ELC (1994) Quality of life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supra-ventricular tachycardia. Am J Cardiol 74:826–829PubMedCrossRefGoogle Scholar
  3. 3.
    Suttorp MJ, Kingma JH, Koomen EM et al (1993) Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ven-tricle function. Am J Cardiol 71:710–713PubMedCrossRefGoogle Scholar
  4. 4.
    Hii JTY, Mitchell B, Duff HJ, Wyse DG, Gillis AM (1992) Comparison of atrial overdrive pacing with and without extrastimuli for termination of atrial flutter. Am J Cardiol 70:463–467PubMedCrossRefGoogle Scholar
  5. 5.
    Baeriswyl G, Zimmerman M, Adamec R (1994) Efficacy of rapid atrial pacing for conversion of atrial flutter in medically treated patients. Clin Cardiol 17:246–250PubMedCrossRefGoogle Scholar
  6. 6.
    Santini M, Pandozi C, Altamura G et al (1999) Single shock endocavitary low energy intracardiac cardioversion of chronic atrial fibrillation. J Interv Card Electrophysiol 3:45–51PubMedCrossRefGoogle Scholar
  7. 7.
    Andersen HR, Nielsen JC, Thomsen PEB et al (1997) Long-term follow up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 350:1210–1216PubMedCrossRefGoogle Scholar
  8. 8.
    Skanes AC, Krahn AD, Yee R et al, for the CTOPP Investigators (2001) Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 38:167–172PubMedCrossRefGoogle Scholar
  9. 9.
    Lamas GA, Lee KL, Sweeney MO et al, for the Mode Selection Trial in sinus node dysfunction (2002) Ventricular pacing or dual chamber pacing for sinus node dysfunction. N Engl J Med 346:1854–1862Google Scholar
  10. 10.
    Sutton R (1999) Is rate response superior to single rate pacing in atrial arrhythmia control? Europace 1:211–212PubMedCrossRefGoogle Scholar
  11. 11.
    Ricci R, Santini M, Puglisi A et al (2001) Impact of consistent atrial pacing algorithm on premature atrial complex number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J Interv Card Electrophysiol 5:33–44PubMedCrossRefGoogle Scholar
  12. 12.
    Boriani G, Biffi M, Padeletti L et al (2001) Effects of consistent atrial pacing and atrial rate stabilization, two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome. Eur Heart J 3(Suppl. P):P7–P15CrossRefGoogle Scholar
  13. 13.
    Camm J (2002) AF therapy study: preventive pacing for paroxysmal atrial fibrillation (abstract). Pacing Clin Electrophysiol 25:554Google Scholar
  14. 14.
    Simpson R, Foster JR, Gettes LS (1982) Atrial excitability and conduction in patients with interatrial conduction defects. Am J Cardiol 50:1331–1337PubMedCrossRefGoogle Scholar
  15. 15.
    Cohen J, Scherf D (1965) Complete interatrial and intra-atrial block (atrial dissociation). Am Heart J 70:24–34CrossRefGoogle Scholar
  16. 16.
    Castillo-Fenoy A, Vernant P (1971) Troubles de la conduction intra-auriculaire par bloc du faisceau de Bachmann. Arch Mal Coeur Vaiss 64:1490–1503Google Scholar
  17. 17.
    D’Allonnes GR, Pavin D, Leclercq C et al (2000) Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience. J Cardiovasc Electrophysiol. 11:1081–1091CrossRefGoogle Scholar
  18. 18.
    Saksena S, Prakash A, Hill M et al (1996) Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 28:687–694PubMedCrossRefGoogle Scholar
  19. 19.
    Mabo P, Paul V, Jung W et al (1999) Biatrial synchronous pacing for atrial arrhythmia prevention: the SYNBIAPACE Study (abstract). Eur Heart J 20(Abs Suppl):4Google Scholar
  20. 20.
    Saksena S, Prakash A, Ziegler P et al, DAPPAF Investigators (2002) Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhyth-mic drug therapy. J Am Coll Cardiol 40:1140–1150PubMedCrossRefGoogle Scholar
  21. 21.
    Padeletti L, Pieragnoli P, Ciapetti C et al (2001) Randomised crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 142:1047–1055PubMedCrossRefGoogle Scholar
  22. 22.
    Bailin SJ, Adler S, Giudici M (2001) Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 12:912–917PubMedCrossRefGoogle Scholar
  23. 23.
    Macdonald P, Hackworthy R, Keogh A et al (1991) Atrial overdrive pacing for reversion of atrial flutter after heart transplantation. J Heart Lung Transplant 10:731–737PubMedGoogle Scholar
  24. 24.
    Peters RW, Shorofsky SR, Pelini M, Olsovsky M, Gold MR (1999) Overdrive atrial pacing for reversion of atrial flutter: comparison of postoperative with nonpostope-rative patients. Am Heart J 137:100–103PubMedCrossRefGoogle Scholar
  25. 25.
    Gloor HO, Fromer M, Kappenberger L (1986) Endocardial conversion of atrial flutter. Success rate of various stimulation protocols. Clin Prog Electrophysiol Pacing 4:67–75Google Scholar
  26. 26.
    Baeriswyl G, Zimmerman M, Adamec R (1994) Efficacy of rapid atrial pacing for conversion of atrial flutter in medically treated patients. Clin Cardiol 17:246–250PubMedCrossRefGoogle Scholar
  27. 27.
    Adler SW, Wolpert C, Warman EN et al, for the Worldwide Jewel AF Investigators (2001) Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 104:887–892PubMedCrossRefGoogle Scholar
  28. 28.
    Ricci R, Pignalberi C, Disertori M et al (2001) Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: the 7250 Dual Defibrillator Italian Registry. Eur Heart J 3(Suppl P):P25–P32CrossRefGoogle Scholar
  29. 29.
    Gold MR, Sulke N, Schwartzman DS, Mehra R, Euler DE, for the Worldwide Jewel AF-Only Investigators (2001) Clinical experience with a dual chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 12:1247–1253PubMedCrossRefGoogle Scholar
  30. 30.
    Steinhaus DM, Cardinal DS, Mongeon L et al (2002) Internal defibrillation: pain perception of low energy shocks. Pacing Clin Electrophysiol 25:1090–1093PubMedCrossRefGoogle Scholar
  31. 31.
    Wijffels M, Kirchhoff C, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954–1968CrossRefGoogle Scholar
  32. 32.
    Wellens HJJ, Lau CP, Luderitz B et al (1998) Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98:1651–1656PubMedCrossRefGoogle Scholar
  33. 33.
    Tse HF, Lau CP, Yu CM et al (1999) Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation. J Cardiovasc Electrophysiol 10:1200–1209PubMedCrossRefGoogle Scholar
  34. 34.
    Friedman PA, Dijkman B, Warman EN et al, for the Worldwide Jewel AF Investigators (2001) Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation. 104:1023–1028PubMedCrossRefGoogle Scholar
  35. 35.
    Schoels W, Swerdlow CD, Jung W et al, for the Worldwide Jewel AF Investigators (2001) Worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 12:521–528PubMedCrossRefGoogle Scholar
  36. 36.
    Ricci R, Pignalberi C, Disertori M et al (2002) Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 23:1471–1479PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • M. Santini
    • 1
  • R. Ricci
    • 1
  • C. Pignalberi
    • 1
  • M. Russo
    • 1
  • B. Magris
    • 1
  • L. Santini
    • 1
  1. 1.Department of CardiologySan Filippo Neri HospitalRomeItaly

Personalised recommendations